Novartis Institutes-Bio Med - 92121 San Diego, CA

Business Name: Novartis Institutes-Bio Med
Categorized In: Commercial Biotechnical Research
Address: 10675 John J Hopkins Drive, San Diego, CA 92121
Phone Number: (858) 812-1500
Contact Person: Ki Song, IT Executive
Website Address: gnf.org
NAICS Code: 6215110
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 1998
Employee #: 1 to 4
Location Type: Branch
Annual Revenue ($): $2.500.000 to $4.999.999
Share This Business:
Similar Businesses: Proacta Inc - San Diego, CA 92121
Abide Therapeutics - San Diego, CA 92121
Miltenyi Biotec Inc - San Diego, CA 92121
Ignyta - San Diego, CA 92121
Center For Aquaculture Tech - San Diego, CA 92121
Aires Pharmaceuticals Inc - San Diego, CA 92121
Oranox - San Diego, CA 92121
Rd Biosciences Inc - San Diego, CA 92121
Zenobia Therapeutics - San Diego, CA 92121
Arytha Biosciences LLC - San Diego, CA 92121
Abwiz Bio Inc - San Diego, CA 92121
Advantar Laboratories Inc - San Diego, CA 92121
Anaptysbio Inc - San Diego, CA 92121
Nod Pharmaceuticals Inc - San Diego, CA 92121
Kinome Scan - San Diego, CA 92121
Dermatrends Inc - San Diego, CA 92121
One World Lab Inc - San Diego, CA 92121
Motivatrx LLC - San Diego, CA 92121
Mapp Biopharmaceutical Inc - San Diego, CA 92121
Fate Therapeutics Inc - San Diego, CA 92121

Novartis Institutes-Bio Med provides professional Commercial Biotechnical Research from its branch at the coordinates 32.8969,-117.23949.

The company offers B2B variables under the SIC code 8731 and NAICS code 6215110, while making an annual revenue of $2.500.000 to $4.999.999 and hiring a total of 1 to 4 employees.

Founded in 1998, the company can now be visited at 10675 John J Hopkins Drive, San Diego, California 92121 or contacted through representative Ki Song, IT Executive at (858) 812-1500.

For frequently asked questions and further inquiries about professional Commercial Biotechnical Research, get to know more about Novartis Institutes-Bio Med through its company website at gnf.org. Engage with this business on its social media platforms through on Twitter and on Facebook.